Etiologies and Predictors of 30-Day Readmission in Heart Failure: An Updated Analysis

Abstract

Background and Objectives Readmissions in heart failure (HF), historically reported as 20%, contribute to significant patient morbidity and high financial cost to the healthcare system. The changing population landscape and risk factor dynamics mandate periodic epidemiologic reassessment of HF readmissions. Methods National Readmission Database (NRD, 2019) was used to identify HF-related hospitalizations and evaluated for demographic, admission characteristics, and comorbidity differences between patients readmitted vs. those not readmitted at 30-days. Causes of readmission and predictors of all-cause, HF-specific, and non-HF-related readmissions were analyzed. Results Of 48,971 HF patients, the readmitted cohort was younger (mean 67.4 vs. 68.9 years, p≤0.001), had higher proportion of males (56.3% vs. 53.7%), lowest income quartiles (33.3% vs. 28.9%), Charlson comorbidity index (CCI) ≥3 (61.7% vs. 52.8%), resource utilization including large bed-size hospitalizations, Medicaid enrollees, mean length of stay (6.2 vs. 5.4 days), and disposition to other facilities (23.9% vs. 20%) than non-readmitted. Readmission (30-day) rate was 21.2% (10,370) with cardiovascular causes in 50.3% (HF being the most common: 39%), and non-cardiac in 49.7%. Independent predictors for readmission were male sex, lower socioeconomic status, nonelective admissions, atrial fibrillation, chronic obstructive pulmonary disease, chronic kidney disease, anemia, and CCI ≥3. HF-specific readmissions were significantly associated with prior coronary artery disease and Medicaid enrollment. Conclusions Our analysis revealed cardiac and noncardiac causes of readmission were equally common for 30-day readmissions in HF patients with HF itself being the most common etiology highlighting the importance of addressing the comorbidities, both cardiac and non-cardiac, to mitigate the risk of readmission.

Physical activity changes and related factors in chronic heart failure patients during the postdischarge transition period: a longitudinal study

“…However, transition points are vulnerable areas that contribute to high healthcare spending and lapses in quality and safety and are associated with increased hospitalization rates. A study showed that more than one-fifth of CHF patients were readmitted within 30 days, costing $17 billion [ 27 ]. Therefore, rehabilitation during this period is of crucial relevance.…”

Impact of amyloidosis on the outcomes of patients with coronary artery disease: A nationwide analysis

“…29 Heart failure readmissions and further interventions like left ventricular assist devices, if needed, add to the healthcare cost. 34,35 In theorem, coronary revascularization complications, which include pulmonary edema and cardiogenic shock, could occur more frequently in CA. A study showed that in STEMI patients with CA comorbidity, the presence of CA portends a greater risk of cardiogenic shock (12.7%) compared to STEMI patients without CA (7.3%).…”

Mechanical Circulatory Support Systems in the Management of Ventricular Arrhythmias: A Contemporary Overview

“…Patients undergoing VT ablation often have significant comorbidities, such as diabetes; HF; ischemic heart disease; atrial fibrillation; chronic ischemic leukoencephalopathy; and advanced-stage renal failure [ 42 ]. Treating such compromised patients can be challenging, thus a multidisciplinary approach involving various professionals could improve the standard of care for patients undergoing VT ablation under deep sedation and with MCS.…”